TrialFrontiers in immunology2026

Efficacy and safety of reduced-dose daratumumab plus bortezomib and dexamethasone (DVd-lite) in newly diagnosed MGRS patients.

Huan Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.